Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are primarily used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. They work by improving blood flow to coronary arteries or temporarily performing the pumping function of the heart. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.
| Website: | www.abiomed.com |
| Email: | mediarelations@abiomed.com |
| Main Phone: | +1 978 646-1400 |
| Address: | 22 Cherry Hill Drive |
| State: | MA |
| City / Town: | Danvers |
| Country: | USA |
| Postal Code: | 01923 |
| Exchange: | NGS |
| CEO: | Michael R. Minogue |
| Employees: | 1371 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
The dollar was weak until a couple months ago and now it’s at a high and so when the dollar gets strong, it hurts the multinationals.
Stocks edged higher last week as investors digested the latest round of mixed economic and earnings data. In the short term, the market looks a little extended and due for a little
Last week was a bullish week on Wall Street as investors sent stocks higher after the "data" pretty much took a June rate hike off the table. The Fed believes that the economic weakness
Non-Farm Payrolls rose by a less than expected 96,000. The Unemployment rate dropped to 8.1% from 8.3%, as 368,000 people left the labor force. The labor force participation rate fell to 63.5% the
Shares of biotech company Medivation, Inc. (MDVN) gapped up today over 100 percent on news that trials of its experimental new prostate cancer treatment had showed tremendous success. Along with
Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are primarily used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. They work by improving blood flow to coronary arteries or temporarily performing the pumping function of the heart. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.
| Website: | www.abiomed.com |
| Email: | mediarelations@abiomed.com |
| Main Phone: | +1 978 646-1400 |
| Address: | 22 Cherry Hill Drive |
| State: | MA |
| City / Town: | Danvers |
| Country: | USA |
| Postal Code: | 01923 |
| Exchange: | NGS |
| CEO: | Michael R. Minogue |
| Employees: | 1371 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
The dollar was weak until a couple months ago and now it’s at a high and so when the dollar gets strong, it hurts the multinationals.
Stocks edged higher last week as investors digested the latest round of mixed economic and earnings data. In the short term, the market looks a little extended and due for a little
Last week was a bullish week on Wall Street as investors sent stocks higher after the "data" pretty much took a June rate hike off the table. The Fed believes that the economic weakness
Non-Farm Payrolls rose by a less than expected 96,000. The Unemployment rate dropped to 8.1% from 8.3%, as 368,000 people left the labor force. The labor force participation rate fell to 63.5% the
Shares of biotech company Medivation, Inc. (MDVN) gapped up today over 100 percent on news that trials of its experimental new prostate cancer treatment had showed tremendous success. Along with
| Last Price 178.87 | Change $ -0.88 | Change % -0.49 | Tick N/A |
| Bid 179.50 | Bid Size 100.00 | Ask 188.00 | Ask Size 400.00 |
| Open 179.53 | High 181.89 | Low 178.05 | Prev Close 179.75 |
| Last Trade | Volume 478,991 | 52 Wk Hi 364.31 | 52 Wk Low 155.03 |
| Market Cap 8.1 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 45,155,108.00 | EPS (TTM) 4.78 | PE Ratio 37.60 | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 87 | 136 |
| Number of Buys | 26 | 51 |
| Number of Sells | 61 | 85 |
| Net Activity | -129445 | -128524 |
| Last 10 Buys | Shares |
|---|---|
| Martin P. Sutter | 1,000 |
| Henri A. Termeer | 1,000 |
| Henri A. Termeer | 1,000 |
| Henri A. Termeer | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Martin P. Sutter | 1,000 |
| Martin P. Sutter | 1,000 |
| Martin P. Sutter | 1,000 |
| Martin P. Sutter | 1,000 |
| Martin P. Sutter | 1,000 |
| Martin P. Sutter | 1,000 |
| Martin P. Sutter | 1,000 |
| Martin P. Sutter | 1,000 |
| Martin P. Sutter | 1,000 |
| Martin P. Sutter | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 460 | 460 | 400 | 515 |
| Low Target Price Estimate | 360 | 300 | 300 | 360 |
| Mean Target Price Estimate | 389 | 379.71 | 371.14 | 409.71 |
| Standard Deviation | 35.08 | 48.52 | 35.53 | 57.58 |
| Date of Most Recent Estimate | 06/04/18 | 05/29/18 | 05/24/18 | 06/12/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 11-K | An annual report of employee stock purchase savings and similar plans | 16 | 2018-06-14 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-25 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-25 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-25 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-25 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-25 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-25 |
| SD | Specialized Disclosure Report | 4 | 2018-05-24 |
| 10-K | Annual report with a comprehensive overview of the company | 134 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-18 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 |
| Moderate Buy | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.56 | 1.56 | 1.56 | 1.56 |
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait